Skip to main content
SpringerLink
Log in

Prognostic and Predictive Factors in the Management of Carcinoma Endometrium

  • Chapter
Uterine Cancer

  • 1185 Accesses

Abstract

Carcinoma Endometrium is the most common gynecological malignancy in the west. It ranks third in India after cervix and ovary. Women with endometrial cancer are usually diagnosed at an early stage, as most present with irregular bleeding or abnormal vaginal discharge and surgery is curative. A few subset of women may present with high risk histological factors or are in an advanced stage of disease. These women will need multimodality treatment to achieve a cure. The overall 5-year survival is 80–90 % in stage 1 tumors. With the advent of molecular and genetic factors, preoperative predictors of poor prognosis are needed to select women for adjuvant treatment to improve the disease free survival.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage 1 and 11 carcinoma of the endometrium. A gynecologic oncology group study. Gynecol Oncol. 1991;40:55.

    Article  CAS  PubMed  Google Scholar 

  2. Christopherson WM, Connelly PJ, Alberhasky RC. Carcinoma of the endometrium. An analysis of prognosticators in patients with favourable subtypes and stage 1 disease. Cancer. 1983;51:1705.

    Article  CAS  PubMed  Google Scholar 

  3. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Uterine Neoplasm. 2014; Version 1.

    Google Scholar 

  4. Hendrickson M, Ross J, Eifel PJ, et al. Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine carpus. Pathol review and analysis of prognostic variables. Gynecol Oncol. 1982;13(3):373–92.

    Article  CAS  PubMed  Google Scholar 

  5. Nori D, Hilaris BS, Tame M, et al. Combined surgery and radiation in endometrial carcinoma; an analysis prognostic factors. Int J Radiat Oncol Biol Phys. 1987;13(4):489–97.

    Article  CAS  PubMed  Google Scholar 

  6. De Góis NM, Martins NV, Abrão FS. Peritumorous lymph-vascular invasion, grade of histologic differentiation, and myometrial infiltration as prognostic factors of endometrial carcinoma. Rev Paul Med. 1993;111(3):385–90.

    PubMed  Google Scholar 

  7. Trimble EWL, Jones HW. Management of stage 11 endometrial carcinoma. Obstet Gynecol. 1988;71:323–6.

    CAS  PubMed  Google Scholar 

  8. Doll KM, Denslow S, Tseng J, et al. Clinical study predictive and prognostic factors in definition of risk groups in endometrial carcinoma. J Clin Oncol. 2013;31 Suppl; abstr 5589.

    Google Scholar 

  9. Mariani A, Webb MJ, Keeney GL, et al. Surgical stage I endometrial cancer: predictors of distant failure and death. Gynecol Oncol. 2002;87:274–80.

    Article  PubMed  Google Scholar 

  10. Shah C, Johnson EB, Everett E, et al. Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer. Gynecol Oncol. 2005;99:564–70.

    Article  PubMed  Google Scholar 

  11. Chitrathara K, Khan A, Neetha S, et al. Discrepancy between clinicoradiological and surgicopathological staging in stage 1 carcinoma endometrium: identification of risk factors. Indian J Cancer 2014; (accepted for publication in 2014).

    Google Scholar 

  12. Creaseman WT, Morrow CP, Bundy L, et al. Surgical pathological spread patterns of endometrial cancer. Cancer. 1987;60:2035.

    Article  Google Scholar 

  13. Turner DA, Gershenson DM, Atkinson N, Sneige N, Wharton AT. The prognostic significance of peritoneal cytology for stage I endometrial cancer. Obstet Gynecol. 1989;74:775–80.

    CAS  PubMed  Google Scholar 

  14. Kadar N, Homesly HD, Malfenato JH. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease. Gynecol Oncol. 1992;46(2):145–9.

    Article  CAS  PubMed  Google Scholar 

  15. McLellan R, Dillon MB, Currie JL, Rosenshein NB. Peritoneal cytology in endometrial cancer: a review. Obstet Gynecol Surv. 1989;44:711–9.

    Article  CAS  PubMed  Google Scholar 

  16. Lurain JR. The significance of positive peritoneal cytology in endometrial cancer. Gynecol Oncol. 1992;46:143–4.

    Article  CAS  PubMed  Google Scholar 

  17. Hirai Y, Takeshima N, Kato T, Hasumi K. Malignant potential of positive peritoneal cytology in endometrial cancer. Obstet Gynecol. 2001;97:725–8.

    Article  CAS  PubMed  Google Scholar 

  18. Kasamatsu T, Onda T, Katsumata N. Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus. Br J Cancer. 2003;88(2):147–50.

    Article  PubMed Central  Google Scholar 

  19. Mundt AJ, Waggoner S, Yamada D. Age as a prognostic factor for recurrence in patients with endometrial carcinoma. Gynecol Oncol. 2000;79:79–85.

    Article  CAS  PubMed  Google Scholar 

  20. Fleming ND, Lentz SE, Cass I. Is older age a poor prognostic factor in stage I and II endometrioid endometrial adenocarcinoma? Gynecol Oncol. 2011;120(2):189–92.

    Article  PubMed  Google Scholar 

  21. Kosary CL. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973–87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol. 1994;10(1):31–46.

    Article  CAS  PubMed  Google Scholar 

  22. Hicks ML, Kim W, Abrams J, Johnson CC. Racial differences in surgically staged patients with endometrial cancer. J Natl Med Assoc. 1997;89(2):134–40.

    PubMed Central  CAS  PubMed  Google Scholar 

  23. Allard JE, Maxwell GL. Race disparities between black and white women in the incidence, treatment, and prognosis of endometrial cancer. Cancer Control. 2009;16(1):53–6.

    PubMed  Google Scholar 

  24. Sorbe B. Clinical study; Predictive and prognostic factors in definition of risk groups in endometrial carcinoma. ISRN Obstet Gynecol. 2012:Article ID 325790.

    Google Scholar 

  25. Gadducci A, Cavazzana A, Cosio S, et al. Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I–II endometrioid-type endometrial cancer. Anticancer Res. 2009;29(5):1715–20.

    PubMed  Google Scholar 

  26. Narayan K, Khaw P, Bernshaw D, et al. Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy. Int J Gynecol Cancer. 2012;22(2):260–6.

    Article  PubMed  Google Scholar 

  27. Loizzi V, Cormio G, Lorusso M, et al. The impact of lymph vascular space invasion on recurrence and survival in patients with early stage endometrial cancer. Eur J Cancer Care (Engl). 2014;23(3):380–4. doi:10.1111/ecc.12115. Epub 23 Sept 2013.

    Article  CAS  Google Scholar 

  28. Hongberg T, Signorelli C, de Olivera CF, et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer-results of two randomized studies. Eur J Cancer. 2010;36(2):371–8.

    Google Scholar 

  29. Sorbe B, Nordestrom J, Maepaa J, et al. Intravaginal brachytherapy in FIGO stage1 low risk endometrial cancer; a controlled randomized study. Int J Gynecol Cancer. 2009;19(5):873–8.

    Article  PubMed  Google Scholar 

  30. Sorbe B, Horvath G, Anderson H, et al. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium risk endometrial carcinoma- a prospective randomized study. Int J Radiat Oncol Biol Phys. 2012;82(3):1249–55.

    Article  PubMed  Google Scholar 

  31. Espino-strebel EE, Luna JTP. Correlation between pre-operative serum CA 125 and surgicopathologic prognostic factors. Gynecol Obstet. ISSN: 2161-0932.

    Google Scholar 

  32. Denschlag D, Tan L, Patel S, et al. Stage III endometrial cancer: preoperative predictability, prognostic factors, and treatment outcome. Am J Obstet Gynecol. 2007;196(6):546e1–7.

    Article  Google Scholar 

  33. Lo SS, Cheng DK, Ng TY, et al. Prognostic significance of tumour markers in endometrial cancer. JCT. 2013:966–970.

    Google Scholar 

  34. Hetzel DJ, Wilson TO, Keeney GL, et al. HER-2/neu expression: a major prognostic factor in endometrial cancer. Gynecol Oncol. 1992;47(2):179–85.

    Article  CAS  PubMed  Google Scholar 

  35. Gurpride E. Endometrial cancer: biochemical and clinical correlates. J Natl Cancer Inst. 1991;83(6):406–16.

    Google Scholar 

  36. Salvesen HB, Iversen OE, Akslen LA. A population-based endometrial carcinoma study – prognostic significance of angiogenesis and Ki-67, p53, and p21 expression. J Clin Oncol. 1999;17(5):1382–90.

    CAS  PubMed  Google Scholar 

  37. Creasman WT. Prognostic significance of hormone receptors in endometrial cancer. Cancer. 1993;71(4 Suppl):1467–70.

    Article  CAS  PubMed  Google Scholar 

  38. Carcangiu ML, Chambers JT, Voynick IM, et al. Immunohistochemical evaluation of oestrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part 1: clinical and histological correlation. Am J Clin Pathol. 1990;94(3):247–54.

    CAS  PubMed  Google Scholar 

  39. Chambers JT, Carcangiu ML, Voynick IM, et al. Immunohistochemical evaluation of oestrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part 11: correlation between biochemical and immunohistochemical methods and survival. Am J Clin Pathol. 1990;94(3):255–60.

    CAS  PubMed  Google Scholar 

  40. Ingram SS, Rosenman J, Heath R, et al. The predictive value of progesterone receptor levels in endometrial cancer. Int J Radiat Oncol Biol Phys. 1989;17(1):21–7.

    Article  CAS  PubMed  Google Scholar 

  41. Huvila J, Talve L, Carpén O, et al. A progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma. Gynecol Oncol. 2013;130(3):463–9.

    Article  CAS  PubMed  Google Scholar 

  42. Yao YY, Xu WZ, Wang Y, et al. Relationships between the molecular biomarkers and the clinicopathologic features and prognosis in endometrial carcinoma. Beijing Da Xue Xue Bao. 2011;43(5):743–8. English abstract.

    CAS  PubMed  Google Scholar 

  43. Susini T, Baldi F, Howard CM, et al. Expression of the retinoblastoma-related gene Rb2/p130 correlates with clinical outcome in endometrial cancer. J Clin Oncol. 1998;16:1085–93.

    CAS  PubMed  Google Scholar 

  44. Susini T, Massi D, Paglierani M, et al. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma. Hum Pathol. 2001;32(4):360–7.

    Article  CAS  PubMed  Google Scholar 

  45. Mhawech-Fauceglia P, Wang D, Kim G, et al. Expression of DNA repair proteins in endometrial cancer predicts disease outcome. Gynecol Oncol. 2014;132(3):593–8. doi:10.1016/j.ygyno.2014.02.002. Epub 6 Feb 2014.

    Article  CAS  PubMed  Google Scholar 

  46. Gao QL, Ye F, Li J, et al. PTEN coding product: a marker for tumorigenesis and progression of endometrial carcinoma. Ai Zheng. 2003;22(6):640–4.

    CAS  PubMed  Google Scholar 

  47. Pallares J, Bussaglia E, Martínez-Guitarte JL, et al. Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities. Mod Pathol. 2005;18(5):719–27.

    Article  CAS  PubMed  Google Scholar 

  48. Konstantinos K, Marios S, Anna M, et al. Expression of p53 in imprint smears of endometrial carcinoma. Diagn Cytopathol. 2014;42(5):416–22. doi:10.1002/dc.23056. Epub 25 Oct 2013.

    Article  PubMed  Google Scholar 

  49. Inaba F, Yamazaki T, Fukasawa I, et al. Endometrial adenosquamous carcinoma with osteoclast-like giant cells: immunohistochemistry and histogenesis. Oncol Rep. 2005;13(1):17–24.

    CAS  PubMed  Google Scholar 

  50. Karaayvaz M, Zhang C, Liang S. Prognostic significance of miR-205 in endometrial cancer. 2012. doi:10.1371/journal.pone.0035158

  51. Ugaki H, Yoshino K, Fujita M, et al. Endometrial carcinoma with extra-abdominal metastasis: improved prognosis following cytoreductive surgery. Ann Surg Oncol. 2010;17(4):1111–7. doi:10.1245/s10434-009-0892-8.

    Article  PubMed  Google Scholar 

  52. Ghassan A, Bernardini MQ, Ren-Chin Wu RC, et al. ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas. Mod Pathol. 2014;27:255–61. doi:10.1038/modpathol.2013.144.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical and Gynecologic Oncology, Welcare Hospital, Kochi, India

    K. Chitrathara MD(Gynec), M.Ch(Uro), FAIS (ICRETT Fellowship in Oncology)

  2. Lakeshore Hospital and Research Centre, Kochi, India

    K. Chitrathara MD(Gynec), M.Ch(Uro), FAIS (ICRETT Fellowship in Oncology)

Authors
  1. K. Chitrathara MD(Gynec), M.Ch(Uro), FAIS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Chitrathara MD(Gynec), M.Ch(Uro), FAIS .

Editor information

Editors and Affiliations

  1. Obstetrics and Gynecology, University College of Medical Sciences, New Delhi, India

    Shalini Rajaram

  2. Surgical &Gynec Oncology, Lakeshore & Welcare Hospitals, Kochi, Kerala, India

    Chitrathara K

  3. Gynec Onclogy, Tata Memorial Hospital, Mumbai, India

    Amita Maheshwari

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer India

About this chapter

Cite this chapter

Chitrathara, K. (2015). Prognostic and Predictive Factors in the Management of Carcinoma Endometrium. In: Rajaram, S., K, C., Maheshwari, A. (eds) Uterine Cancer. Springer, New Delhi. https://doi.org/10.1007/978-81-322-1892-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-81-322-1892-0_12

  • Publisher Name: Springer, New Delhi

  • Print ISBN: 978-81-322-1891-3

  • Online ISBN: 978-81-322-1892-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation